Statement by ResMed on United Kingdom Case with Fisher & Paykel

SAN DIEGO, Nov. 12, 2017 /PRNewswire/ -- ResMed (NYSE: RMD, ASX: RMD) today issued the following statement from David Pendarvis, the company's global general counsel and chief administrative officer: "While we are disappointed the English Patents Court has ruled that ResMed's patent E...